Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 1
2005 3
2006 8
2007 13
2008 7
2009 15
2010 9
2011 10
2012 15
2013 20
2014 16
2015 13
2016 31
2017 31
2018 32
2019 33
2020 41
2021 61
2022 86
2023 75
2024 118
2025 148
2026 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

724 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Xing M, Ma Y, Cui F, Li D, Wang J, Tang L, Zheng L, Yang J, Tian Y. Xing M, et al. Among authors: wang j. Arthritis Rheumatol. 2025 Jan;77(1):116-117. doi: 10.1002/art.42980. Epub 2024 Sep 12. Arthritis Rheumatol. 2025. PMID: 39187473 No abstract available.
Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody-Drug Conjugate TAK-500.
Appleman VA, Matsuda A, Ganno ML, Zhang DM, Rosentrater E, Maldonado Lopez AE, Porciuncula A, Hatten T, Christensen CL, Merrigan SA, Lee HM, Lee MY, Wang CI, Dong L, Huang J, Iartchouk N, Wang J, Xu H, Yoneyama T, Piatkov KI, Haridas S, Harbison CE, Gregory RC, Parent A, Lineberry N, Arendt C, Schalper KA, Abu-Yousif AO. Appleman VA, et al. Among authors: wang j. Cancer Immunol Res. 2025 May 2;13(5):661-679. doi: 10.1158/2326-6066.CIR-24-0103. Cancer Immunol Res. 2025. PMID: 39918395 Free PMC article.
Preclinical Characterization of ARX517, a Site-Specific Stable PSMA-Targeted Antibody-Drug Conjugate for the Treatment of Metastatic Castration-Resistant Prostate Cancer.
Skidmore LK, Mills D, Kim JY, Knudsen NA, Nelson JD, Pal M, Wang J, Gc K, Gray MJ, Barkho W, Nagaraja Shastri P, Ramprasad MP, Tian F, O'Connor D, Buechler YJ, Zhang SS. Skidmore LK, et al. Among authors: wang j. Mol Cancer Ther. 2024 Dec 3;23(12):1842-1853. doi: 10.1158/1535-7163.MCT-23-0927. Mol Cancer Ther. 2024. PMID: 39172730 Free PMC article.
724 results